IRIS
MASSIRONI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.292
EU - Europa 3.109
NA - Nord America 2.559
SA - Sud America 687
Continente sconosciuto - Info sul continente non disponibili 269
AF - Africa 62
OC - Oceania 3
Totale 9.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.405
RU - Federazione Russa 1.871
SG - Singapore 1.098
CN - Cina 894
IT - Italia 595
BR - Brasile 537
HK - Hong Kong 469
VN - Vietnam 332
BD - Bangladesh 232
FR - Francia 175
DE - Germania 106
GB - Regno Unito 90
IN - India 60
MX - Messico 57
CA - Canada 54
AR - Argentina 53
SE - Svezia 40
NL - Olanda 37
ES - Italia 34
AT - Austria 33
FI - Finlandia 33
PL - Polonia 33
TR - Turchia 30
ID - Indonesia 28
CO - Colombia 27
ZA - Sudafrica 23
JP - Giappone 22
IQ - Iraq 20
EC - Ecuador 17
VE - Venezuela 14
MY - Malesia 12
JM - Giamaica 11
SA - Arabia Saudita 11
PH - Filippine 10
PK - Pakistan 10
UY - Uruguay 10
CL - Cile 9
MA - Marocco 9
PY - Paraguay 9
LT - Lituania 8
MD - Moldavia 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
UA - Ucraina 7
CR - Costa Rica 6
DZ - Algeria 6
IE - Irlanda 6
NP - Nepal 6
UZ - Uzbekistan 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
JO - Giordania 5
PE - Perù 5
PT - Portogallo 5
TW - Taiwan 5
CY - Cipro 4
GT - Guatemala 4
OM - Oman 4
BE - Belgio 3
BN - Brunei Darussalam 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 9.705
Salva come PNG Salva come JPEG
Città #
Singapore 570
Hong Kong 458
Dallas 453
Moscow 393
San Jose 381
Ashburn 334
Hefei 160
Milan 139
Lauterbourg 136
Beijing 134
New York 116
Ho Chi Minh City 111
Shanghai 88
Hanoi 77
Santa Clara 67
Los Angeles 64
São Paulo 58
Council Bluffs 46
Rome 43
Orem 40
Nuremberg 33
Warsaw 29
Buffalo 28
Mexico City 27
Naples 26
Turin 25
Montreal 24
Atlanta 22
Brooklyn 20
Tokyo 20
Da Nang 19
London 19
Chicago 18
Munich 18
Rio de Janeiro 18
Frankfurt am Main 17
Amsterdam 16
Houston 16
Haiphong 15
Helsinki 15
Bari 14
Bologna 14
Charlotte 14
Denver 14
Figino 14
Poplar 14
Stockholm 14
Chennai 13
Omaha 13
Ankara 12
Falkenstein 12
Johannesburg 12
Phoenix 12
San Francisco 12
Vienna 12
Boardman 11
Brasília 11
Curitiba 11
Genoa 11
Lappeenranta 11
Seattle 11
Brescia 10
Las Vegas 10
Manchester 10
Memphis 10
Mumbai 10
Palermo 10
Catania 9
Guangzhou 9
Miami 9
Quito 9
Thái Bình 9
Assago 8
Boston 8
Detroit 8
Hải Dương 8
Lawrence 8
Toronto 8
Baghdad 7
Belo Horizonte 7
Dhaka 7
Ribeirão Preto 7
Stezzano 7
Tianjin 7
Turku 7
Barnet 6
Bogotá 6
Chengdu 6
Columbus 6
Dublin 6
Duque de Caxias 6
Jakarta 6
Montevideo 6
Paris 6
Philadelphia 6
Porto Alegre 6
Princeton 6
Querétaro 6
San José 6
São Gonçalo 6
Totale 4.847
Salva come PNG Salva come JPEG
Nome #
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 185
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 163
Inflammation and malnutrition in inflammatory bowel disease 123
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 113
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 112
Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review 112
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 109
Autoimmune pancreatitis: Cornerstones and future perspectives 107
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 103
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 100
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 100
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 100
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 97
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 97
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 95
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 95
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection 94
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 89
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 88
Advancements in Barrett's esophagus detection: The role of artificial intelligence and its implications 86
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CME 86
Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease : overview of available evidence and open issues 86
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database 85
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 84
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 83
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 83
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature 82
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature 81
Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity 81
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors. 81
"Pseudotumoral” hepatic pattern in acute alcoholic hepatitis : a case report 78
Unraveling the Microbiome's Role in Neuroendocrine Neoplasms: A New Perspective 78
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 76
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival 76
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 75
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight-control strategy? 75
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 75
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios 74
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review 73
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 73
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 72
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms 70
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 69
Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review 69
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights 68
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 68
Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms 68
An unusual endoscopic feature in the duodenum of a young girl with intraluminal duodenal diverticulum 68
"Pseudotumoral" hepatic areas in acute alcoholic hepatitis: A computed tomography and histological study 67
A case of positive 68Ga-DOTATOC-PET/CT pancreatic heterotopia mimicking an intestinal neuroendocrine tumor 64
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review 64
Plasma chromogranin A in patients with inflammatory bowel disease 64
Endoscopic Ultrasound Elastography in Pancreatic Diseases EUS-EG in Pancreatic Diseases 62
Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis 60
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 59
High rates of 30-day mortality in patients with cirrhosis and COVID-19 59
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 59
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms 59
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 58
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 58
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 56
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution 56
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis. 56
Systematic review-Pancreatic involvement in inflammatory bowel disease 55
Small Bowel Ultrasound beyond Inflammatory Bowel Disease: An Updated Review of the Recent Literature 54
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 53
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study 53
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NONCARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 53
Gastric carcinoids : between underestimation and overtreatment 52
Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor : a case report with review of the literature 51
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study 51
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 51
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 51
Should patients with IBS be submitted to painful rectal distention in clinical practice? [1] 51
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis 51
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 50
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 50
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 50
Primary sclerosing cholangitis associated with inflammatory bowel disease : An update 50
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 50
Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours : Literature review, clinical recommendations and schedules 49
Understanding short bowel syndrome : current status and future perspectives 49
Gastric neuroendocrine neoplasms and proton pump inhibitors : fact or coincidence? 49
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B 49
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 49
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm 49
Neuroendocrine tumors of the gastro-entero-pancreatic system 49
Neuroendocrine neoplasms of rectum: A management update 48
Drug side-effects in IBD [1] 48
Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) 48
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 48
Clinical impact of endoscopic ultrasonography on the management of neuroendocrine tumors: lights and shadows 48
Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors 47
Circulating ghrelin levels in patients with inflammatory bowel disease [1] 47
Endoscopic techniques for gastric neuroendocrine tumors: An update 47
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 46
Hepatic hemangioma in celiac patients : data from a large consecutive series 46
The diagnostic challenges of functioning neuroendocrine tumors: balancing accuracy, availability, and personalized care 46
Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It? 46
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 46
Totale 7.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.972
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 1 0 1 0 0 0 0 0 1
2022/202360 16 5 3 4 2 9 7 6 4 0 0 4
2023/202448 0 3 2 6 5 6 3 4 3 1 5 10
2024/20251.512 25 2 5 122 41 129 299 98 206 282 137 166
2025/20267.871 529 589 538 848 600 389 715 533 1.832 470 355 473
2026/2027481 436 45 0 0 0 0 0 0 0 0 0 0
Totale 9.981